Finance

Lists
PVCT:OTCMKTS
Provectus Biopharmaceuticals Inc
$0.057
-3.18%
(-0.0019) 1D
Aug 31, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PVCT...
Open
$0.06
High
$0.06
Low
$0.05
Mkt. cap
23.13M
Avg. vol.
171.11K
Volume
210.46K
52-wk high
$0.09
52-wk low
$0.04
EPS
-$0.01
Beta
0.86
Shares outstanding
420.28M
No. of employees
6
Open
$0.06
High
$0.06
Low
$0.05
Mkt. cap
23.13M
Avg. vol.
171.11K
Volume
210.46K
52-wk high
$0.09
52-wk low
$0.04
EPS
-$0.01
Beta
0.86
Shares outstanding
420.28M
No. of employees
6
About Provectus Biopharmaceuticals Inc
CEO-
Employees6
Founded2002
HeadquartersKnoxville, Tennessee, United States
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
323.22K
248.94K
310.93K
108.06K
Cost of revenue
323.22K
248.94K
310.93K
108.06K
Research and development expenses
13.64K
13.64K
13.34K
13.49K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
831.08K
761.24K
923.63K
737.40K
Operating expense
844.72K
774.88K
936.98K
750.89K
Total operating expenses
1.17M
1.02M
1.25M
858.95K
Operating income
-1.17M
-1.02M
-1.25M
-858.95K
Other non operating income
-
-
-
-
EBT including unusual items
-1.32M
-1.17M
-1.30M
-988.72K
EBT excluding unusual items
-1.22M
-1.07M
-1.30M
-909.27K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.31M
-1.17M
-1.29M
-982.57K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-48.02K
-47.32K
-53.05K
-50.32K
Net interest expenses
-48.02K
-47.32K
-53.05K
-50.32K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.17M
-1.02M
-1.25M
-858.48K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps